
ParcelBio YC Application
ParcelBio went through Y Combinator in the Winter 2024 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2024
- Industry
- HealthcareTherapeutics
- Team size
- 6
- Status
- Active
- Launched
- 2024
Founders
David WeinbergFounder
Chris CarlsonFounder
What ParcelBio does
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
ParcelBio's YC application, reconstructed
Y Combinator application
ParcelBio, Winter 2024 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
ParcelBio
Elevated mRNA for transformative medicines
We are building a new class of mRNA medicines that deliver much higher protein expression and longer activity using our proprietary APEXm™ platform. This enables therapies targeting autoimmune diseases, cancer, and protein therapeutics with potency and duration not achievable by existing mRNA drugs.
We live and operate in San Francisco, and after YC we will continue to be based here.
San Francisco has the critical biotech ecosystem, access to talent, and investors necessary for a therapeutics startup focused on mRNA medicines. It's where we can recruit, collaborate, and raise effectively.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real ParcelBio YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from ParcelBio's public data (launch notes, founder backgrounds, product description). It shows how a company like ParcelBio would present itself to YC, not the text they submitted.
What YC batch was ParcelBio in?
ParcelBio was part of the Y Combinator Winter 2024 batch.
Who founded ParcelBio?
ParcelBio was founded by David Weinberg, Chris Carlson.
What does ParcelBio do?
Elevated mRNA for transformative medicines.
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of ParcelBio's application, and every other YC batch, is in YC Insights.